Yu, Yongfeng
Yao, Fei
Wang, Jin
Huang, Zhan
Hu, Tao
Zhu, Changbin
Lu, Shun
Funding for this research was provided by:
National Natural Science Foundation of China (82030045, 82241227)
National Natural Science Foundation of China (82030045, 82241227)
National Multi-disciplinary Treatment Project for Major Diseases (2020NMDTP)
National Multi-disciplinary Treatment Project for Major Diseases (2020NMDTP)
Collaborative Innovation Center for Clinical and Translational Science by Ministry of Education & Shanghai (TM202112, CCTS202204, CCTS202304)
Collaborative Innovation Center for Clinical and Translational Science by Ministry of Education & Shanghai (TM202112, CCTS202204, CCTS202304)
Article History
Received: 29 March 2024
Accepted: 10 June 2025
First Online: 3 July 2025
Declarations
:
: This study was approved by the institutional review board of the Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine (Ethics ID:IS22059).
: All patients provided written informed consent before molecular diagnosis, participation in this study was covered by this protocol.
: The authors declare no competing interests.